1.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: D8480C00013, Eudract Number 2005-003440-66, NCT00384176
|
|
2.
|
Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: BR24, CAN-NCIC-BR24, ZENECA-CAN-NCIC-BR24, FHCRC-6107, UWCC-UW 6107, UWCC- 06-2707-H/B, CDR0000450850, NCT00245154
|
|
3.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 2007-001346-41, ISRCTN68510403, NCT00532194
|
|
4.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: D8480C00051, EUDRACT No 2006-001194-14, HORIZON II, NCT00399035
|
|
5.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: D8480C00055, NCT00777153
|
|
6.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: BR29, CAN-NCIC-BR29, CDR0000618671, NCT00795340
|
|
7.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: D8480C00039, NCT00494221
|
|
8.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: MGH-07-344, 07-344, PHS 398/2590, 8030, NCT00662506
|
|
9.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000445438, DFCI-05160, NCI-7099, 7099, NCT00244881
|
|
10.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: PMH-PHL-039, 7128, NCI-7128, NCT00227760
|
|
11.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N044J, N044J, NCT00238394
|
|
12.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000446178, U10CA032102, SWOG-S0509, S0509, NCT00243074
|
|
13.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000446554, PMH-PHL-038, 7137, NCT00243061
|
|
14.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000448627, P30CA033572, CCC-PHII-64, NCI-7097, 7097, NCT00245063
|
|
15.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: DFCI 05-170, P30CA006516, NCI-7102, CDR0000455590, 7102, NCT00275028
|
|
16.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000456204, PMH-PHL-037, NCI-7129, 7129, NCT00278343
|
|
17.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MGH-05-254, NCI-7105, 7105, NCT00305656
|
|
18.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: UCCRC-NCI-7111, 7111, NCI-7111, NCT00303862
|
|
19.
|
Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: D8480C00038, EUDRACT Number 2005-003442-33, NCT00264004
|
|
20.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00126, N01CM17102, CDR0000463521, 14203B, UCCRC-14203B, NCI-7103, 7103, NCT00309946
|
|
21.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N048F, N048F, NCT00321724
|
|
22.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: D8480C00041, EUDRACT number 2005-003443-31, HORIZON I, NCT00278889
|
|
23.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N0528, N0528, NCT00326599
|
|
24.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00128, CDR0000475761, N01CM17104, MC047F, MAYO-MC047F, 7133, NCI-7133, NCT00326872
|
|
25.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: D8480C00021, 2005-003441-13, NCT00306891
|